Rhinomed Ltd is a medical technology company, with a patented nasal technology platform. It is engaged in research, development and commercialization of consumer and medical devices including nasal, respiratory and nasal drug delivery technologies.
(As of Friday Closing)
Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
---|---|---|---|---|---|---|
$0.10 | $0.10 | $0.03 - $0.14 | $24.6M | 254M | 141K | -$0.02 |
In Thousands, USD |
TTM 31-Dec-2020 | FY 2020 30-Jun-2020 | FY 2019 30-Jun-2019 | FY 2018 30-Jun-2018 |
---|---|---|---|---|
EV | 27,449 | 7,107 | 19,676 | 12,647 |
Revenue | 2,644 | 2,388 | 2,350 | 1,680 |
EBITDA | (4,709) | (4,447) | (3,969) | (2,882) |
Net Income | (5,126) | (4,867) | (4,248) | (3,102) |
Total Assets | 7,642 | 8,804 | 4,112 | 4,340 |
Total Debt | 408 | 404 | 0 | 0 |
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
This information is available in the PitchBook Platform. To explore Rhinomed‘s full profile, request access.
Request a free trialName | Title | Board Seat | Contact Info |
---|---|---|---|
Michael Johnson | Chief Executive Officer & Managing Director | ||
Brooks George | Account Executive |
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|
This information is available in the PitchBook Platform. To explore Rhinomed‘s full profile, request access.
Request a free trialCompany Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
---|---|---|---|---|---|
00000 0000000 | 22-Dec-2011 | 000000000000000000 | 00.00 | Surgical Devices | |
Leading Edge Instruments | 24-Feb-2011 | Merger/Acquisition | Medical Supplies |
Company Name | Industry | Location | Founded |
---|---|---|---|
00000 0000000 | Surgical Devices | Marlborough, MA | 0000 |